Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Amlexanox for Type 2 Diabetes and Obesity

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Elif Oral, University of Michigan
ClinicalTrials.gov Identifier:
NCT01842282
First received: April 24, 2013
Last updated: August 22, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)